Siirry päänavigointiin Siirry hakuun Siirry pääsisältöön

Differential mobility spectrometry classification of bacteria

Tutkimustuotos: ArtikkeliTieteellinenvertaisarvioitu

4 Sitaatiot (Scopus)

Abstrakti

<p>Aim: Rapid identification of bacteria would facilitate timely initiation of therapy and improve cost-effectiveness of treatment. Traditional methods (culture, PCR) require reagents, consumables and hours to days to complete the identification. In this study, we examined whether differential mobility spectrometry could classify most common bacterial species, genera and between Gram status within minutes. Materials & methods: Cultured bacterial sample gaseous headspaces were measured with differential mobility spectrometry and data analyzed using k-nearest-neighbor and leave-one-out cross-validation. Results: Differential mobility spectrometry achieved a correct classification rate 70.7% for all bacterial species. For bacterial genera, the rate was 77.6% and between Gram status, 89.1%. Conclusion: Largest difficulties arose in distinguishing bacteria of the same genus. Future improvement of the sensor characteristics may improve the classification accuracy.</p>
AlkuperäiskieliEnglanti
Sivut233-240
Sivumäärä8
JulkaisuFuture Microbiology
Vuosikerta15
Numero4
DOI - pysyväislinkit
TilaJulkaistu - 2020
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä

Rahoitus

This study was financially supported by the following agents: Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (9s045, 151B03, 9T044, 9U042, 150618, 9U042, 9V044, 9X040 and X51001); Academy of Finland: grant 286284; Finnish Foundation for Cardiovascular Research, Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjö Jahnsson Foundation; Signe and Ane Gyllenberg Foundation; Diabetes Research Foundation of Finnish Diabetes Association and EU Horizon 2020 (grant 755320 for TAXINOMISIS) and Tampere University Hospital Supporting Foundation. Anton Kontunen, Markus Karjalainen, Osmo Anttalainen, Niku Oksala and Antti Roine are shareholders of Olfactomics Ltd, which is about to commercialise proprietary technology for the detection of diseases by ion mobility spectrometry. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.

Tutkimusalat

  • DMS
  • IMS
  • bacteria
  • differential mobility spectrometry
  • eNose
  • ion mobility spectrometry

Julkaisufoorumi-taso

  • Jufo-taso 1

Sormenjälki

Sukella tutkimusaiheisiin 'Differential mobility spectrometry classification of bacteria'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

Siteeraa tätä